Atrion Corporation R&D Expense Quarterly:
1.197M for Dec. 31, 2012Atrion Corporation Historical R&D Expense Quarterly Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 1.197M |
| Sept. 30, 2012 | 0.753M |
| June 30, 2012 | 0.844M |
| March 31, 2012 | 0.973M |
| Dec. 31, 2011 | 0.785M |
| Sept. 30, 2011 | 0.778M |
| June 30, 2011 | 0.728M |
| March 31, 2011 | 0.576M |
| Dec. 31, 2010 | 0.619M |
| Sept. 30, 2010 | 0.76M |
| June 30, 2010 | 0.675M |
| March 31, 2010 | 0.615M |
| Dec. 31, 2009 | 0.863M |
| Sept. 30, 2009 | 0.661M |
| June 30, 2009 | 0.76M |
| March 31, 2009 | 0.77M |
| Dec. 31, 2008 | 0.728M |
| Sept. 30, 2008 | 0.63M |
| June 30, 2008 | 0.823M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
ATRI R&D Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Becton Dickinson | 122.38M |
| Intuitive Surgical | 41.60M |
| Staar Surgical | 1.366M |
ATRI R&D Expense Quarterly Rankings
| Overall |
83rd percentile 1216 of 7590 |
| Sector |
43rd percentile 367 of 651 in Healthcare |
| Industry |
31st percentile 46 of 67 in Medical Instruments & Supplies |
ATRI R&D Expense Quarterly Range, Past 5 Years
| Minimum | 0.5760M | Mar 2011 |
| Maximum | 1.197M | Dec 2012 |
| Average | 0.7652M |